PALO ALTO, Calif.--Incyte Pharmaceuticals here has signed a multiyear database partnership agreement with Organon, a pharmaceutical business unit of Akzo Nobel. The deal will give Organon access to Incyte's LifeSeq gene sequence and expression database and its LifeSeq GeneAlbum reagent set in exchange for annual access fees. Organon will be responsible for developing and commercializing any drugs that arise from the collaboration, but Incyte could receive royalties on sales developed with its technology and databases.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.